Clinical Trial: Evaluation of Dentin Hypersensitivity Using Glass Ionomer Cements

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Evaluation of the Effectiveness of Dentin Hypersensitivity Treatment Using Glass Ionomer Cements: A Randomized Clinical Trial

Brief Summary: The aim of this randomized, double-blind, split-mouth clinical trial is to evaluate and compare the desensitizing efficacies of the resin-modified glass ionomer cement ClinproTM XT (3M ESPE, Minnesota, USA) and the conventional glass ionomer cement Vidrion R (SS White, Gloucester, UK) at 2-year follow-up.

Detailed Summary: Subjects will require to have at least two teeth in different hemiarchs with dentin hypersensitivity. Teeth will be randomized into 2 groups, receiving either Clinpro XT or the conventional glass ionomer cement Vidrion R. Prior to the desensitizing treatment (baseline), painful symptoms will be assessed by tactile and air blast tests using the Visual Analogue Scale (VAS). Treatment evaluations will be conducted up to 2-year post-treatment.
Sponsor: Federal University of Pelotas

Current Primary Outcome: Pain Scores as measured by the Visual Analog Scale (VAS) [ Time Frame: Change from Baseline in Pain Scores at 20 minutes; at 7, 15, 21, 30 days; and after 3, 6, 12, 24 months. ]

Tactile and air blast tests to evaluate pain with VAS


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Federal University of Pelotas

Dates:
Date Received: February 22, 2015
Date Started: April 2014
Date Completion: October 2016
Last Updated: March 3, 2015
Last Verified: February 2015